Skip to main content

Table 2 Median scores of the 23 trials for each domain of the PRECIS-2 tool

From: How pragmatic are the randomised trials used in recommendations for control of glycosylated haemoglobin levels in type 2 diabetic patients in general practice: an application of the PRECIS II tool

Title of domainMedian scoreNumber of articles with missing dataArticles for which scoring required a consensusArticles for which scoring required a consensus between a score rather explanatory (<3) or pragmatic (>3)
(Q1; Q3)N (%)N (%a)N (%a)
Eligibility2 (1; 2))1/23 (4)14/22 (64)1/22 (5)
Recruitment1 (1; 3)10/23 (43)10/13 (77)5/13 (38)
Setting2 (1; 2)3/23 (13)17/20 (85)4/20 (20)
Organisation2 (1; 2)3/23 (13)16/20 (80)1/20 (5)
Flexibility of delivery2 (2; 4)6/23 (26)13/17 (76)1/17 (6)
Flexibility of adherence2 (1.75; 2)9/23 (39)10/14 (71)3/14 (21)
Follow up2 (2; 3)4/23 (17)16/19 (84)1/19 (5)
Primary outcome2 (1; 3.25)3/23 (13)12/20 (60)5/20 (25)
Primary analysis4 (1; 5)6/23 (26)12/17 (71)0/17 (0)
  1. aThe consensus was any discrepancy in the scores between the two researchers (ET and CD-D)